1243TiPPhase I study of BI 754111 (anti-LAG-3) plus BI 754091(anti-PD-1) in patients (pts) with advanced solid cancers, followed by expansion in pts with microsatellite stable metastatic colorectal cancer (mCRC), anti-PD-(L)1-pretreated non-small cell lung cancer (NSCLC) and other solid tumors. (23rd October 2018) - Johnson, M L; Patel, M R; Ulahannan, S V; Hansen, A; George, B; Chu, Q S-C; Elgadi, M; Ge, M; Duffy, C; Graeser, R; Khedkar, S; Jones, S F; et al.